Salmonella
==========

*Salmonella enterica* consists of more than 2500 serovars. *S. enterica* serovar Typhi and Paratyphi cause typhoid in humans, a disease characterized by fever, systemic infection, and gastroenteritis. *S. enterica* serovar Typhi and Paratyphi are estimated to affect more than 16 million people worldwide and cause 600,000 deaths/year. Several non-typhoidal *S. enterica* serovars (NTS) can cause enterocolitis in humans. In infants and immunocompromised patients, NTS can disseminate and cause potentially lethal bacteremia. In the United States, NTS are the leading cause of foodborne disease with an estimated cost of 2 billion dollars/year (Grassl et al., [@B17]; Santos et al., [@B41]).

Mouse Model of *Salmonella* Infections
======================================

*Salmonella enterica* serovar Typhimurium (herein referred to as *Salmonella*) causes enterocolitis in humans. In mice, *Salmonella* cause a systemic infection that resembles human typhoid fever. During the natural infection, *Salmonella* enters the host via the oral route and overcome the defense provided by mucus and the endogenous microbiota. Then *Salmonella* crosses the epithelial barrier, mainly by invading M cells (Hase et al., [@B19]; Knoop et al., [@B22]), an intestinal epithelial cell type specialized in the transport of particles from the gut lumen to the lamina propria. Once in the lamina propria, *Salmonella* can be taken up by dendritic cells (Uematsu and Akira, [@B47]; DC) and transported to Peyer patches and other gut-associated lymphoid tissues, from which *Salmonella* disseminates to other organs such as the liver and/or spleen where they can survive within phagocytic cells. An alternative route for *Salmonella* uptake via DCs that sample the intestinal lumen has been described (Rescigno et al., [@B39]; Niess et al., [@B36]). In resistant mouse strains, *Salmonella* causes chronic infections (Monack et al., [@B33]; Grassl et al., [@B17]) while in susceptible strains *Salmonella* is lethal. Commensal bacteria have an important role in preventing *Salmonella* from colonizing the intestine and causing acute intestinal inflammation (Hapfelmeier and Hardt, [@B18]). Pretreatment with a single dose of the antibiotic streptomycin reduces the presence of commensal bacteria and renders otherwise resistant mice susceptible to *Salmonella* (Hapfelmeier and Hardt, [@B18]). These findings have opened the way to studies aimed at investigating both the bacterial virulence factors and the host response in the acute intestinal inflammation triggered by *Salmonella* in mice.

Bacteria Virulence Factors
==========================

Bacterial secretion systems are molecular machineries used by pathogenic bacteria to deliver effectors proteins inside the host cell and manipulate cell behavior. *Salmonella* encodes two type III protein secretion systems which manipulate host cell behavior through the delivery of specific effectors proteins. One of the systems is encoded within the *Salmonella* pathogenicity island 1 (SPI-1) and is important in the initial phase of infection (Grassl and Finlay, [@B16]); in agreement effectors proteins encoded within the SPI-1 have been implicated in cytoskeletal rearrangement responsible for bacterial uptake by epithelial cells, a step required for the bacteria to breach the intestinal barrier (Grassl and Finlay, [@B16]). The other is encoded within the SPI-2 and has an essential role in bacterial survival during the systemic phase of infection (Monack et al., [@B33]). Effector proteins encoded within the SPI-2 have been shown to be essential for intracellular growth and survival inside macrophages (Grassl and Finlay, [@B16]).

The Host Response
=================

Initial studies aimed at identifying host factors responsible for susceptibility to pathogens identified natural resistance-associated macrophage protein 1 (*NRAMP1*) as a crucial gene in natural resistance to infection by *Salmonella*, *Mycobacterium tuberculosis*, and *Leishmania donovani*. Successive studies have greatly expanded our knowledge about the host factors responsible for defense against *Salmonella*, a topic that has been reviewed in detail elsewhere (Raupach and Kaufmann, [@B37]). Here, I will focus on the role of pattern recognition receptors (PRRs) belonging to the Toll-like receptors (TLR) and Nod-like receptors (NLR) in mounting protective host responses against *Salmonella*.

Role of TLR4 and TLR5 in *Salmonella* Infection
===============================================

The initial detection of microbes is achieved though the detection of conserved microbial structures by PRRs. PRRs comprise an array of sensors present in different cell types and cellular location that control the activation of signaling pathways ultimately aimed at the elimination of invading microbes (Takeuchi and Akira, [@B45]). TLRs localize either at the cell surface or within endosomes, in contrast to NLRs that are located in the host cytosol.

Toll-like receptor 4 recognizes bacterial lipopolysaccharide (LPS), a major constituent of the outer membrane of Gram-negative bacteria (Takeuchi and Akira, [@B45]), such as *Salmonella*. The recognition of LPS by TLR4 is assisted by several proteins such as CD14, LPS-binding protein (LBP), and MD-2. Knockout mice revealed a crucial role of TLR4, LBP, and CD14 in host defense during the systemic phase of *Salmonella* infection (Bernheiden et al., [@B3]). The increased susceptibility to *Salmonella* was attributed to a delayed recruitment of neutrophils allowing increased bacterial growth in liver macrophages (Vazquez-Torres et al., [@B49]), and not to defects in activation of the adaptive immune response (Ko et al., [@B23]).

Toll-like receptor 5 is a sensor of extracellular flagellin, the main component of the flagella, an appendage that is used by bacteria for movement. TLR5 is expressed on the basal surface of intestinal epithelial cells and in a specific population of intestinal DCs (Uematsu et al., [@B48]). Initial experiments using intestinal epithelial cell lines indicate that flagellin, but not LPS, is a powerful inducer of the proinflammatory cytokine IL-8 (Zeng et al., [@B52]). Experiments with polarized intestinal epithelial cell demonstrate that stimulation with flagellin induces an inflammatory response only when in contact with the basolateral surface (Gewirtz et al., [@B14],[@B15]). Together these data suggest that in the intestine, flagellin can activate TLR5 only if it breaches the intestinal epithelial barrier, thus potentially preventing the induction of an inflammatory response against flagellated intestinal commensal bacteria (Vijay-Kumar et al., [@B50]).

While there is evidence that flagellin can trigger the recruitment of immature DCs and other leukocytes through TLR5 in human epithelial cell lines (Sierro et al., [@B42]), the expression of TLR5 in mouse intestinal epithelial cells is low. This is in contrast to specific populations of lamina propria DCs (CD11c^hi^ CD11b^hi^) isolated from the small intestine that express high levels of TLR5 (Uematsu et al., [@B48]). Importantly, while conventional DCs, macrophages, and lamina propria macrophages do not express TLR5 and fail to respond to flagellin, lamina propria DCs stimulated with flagellin produce elevated levels of IL-6 and IL-12 in a TLR5-dependent manner (Uematsu et al., [@B48]). The response of lamina propria DCs was specific for flagellin, in that lamina propria DCs did not respond to stimulation with other TLR ligands such as LPS (Uematsu et al., [@B48]). So it seems that some lamina propria DCs are equipped to mount a proinflammatory response against infectious flagellated bacteria such as *Salmonella*. Surprisingly, TLR5-deficient mice are less susceptible than wild-type mice to infection with *Salmonella* (Uematsu et al., [@B48]). Given that DCs are important for transporting bacteria from the lamina propria to the mesenteric lymph nodes (Uematsu and Akira, [@B47]), it has been suggested that in response to *Salmonella* infection TLR5 plays an important role in the maturation of lamina propria DCs and subsequent migration to mesenteric lymph nodes (Uematsu et al., [@B48]). These data suggest that during *Salmonella* infection the host response mediated by TLR5 in lamina propria DCs is hijacked by the bacterium using intestinal DCs as Trojan horses to cause systemic infection.

Role of NLRs in *Salmonella* Infection
======================================

Nucleotide-binding oligomerization domain 1 (NOD1) and NOD2 sense bacterial molecules produced during the synthesis, degradation, and remodeling of peptidoglycan (PGN). NOD2 is expressed in a variety of different cells types including macrophages, DCs, and Paneth cells. NOD2 senses muramyl dipeptide (MDP), a moiety found in PGN of nearly all Gram-positive and Gram-negative organisms. Genetic studies revealed that several NOD2 variants are associated with susceptibility to Crohn\'s disease (CD), a chronic disorder characterized by transmural inflammation of the intestine, particularly in the distal ileum. NOD1 is ubiquitously expressed and recognizes γ-[D]{.smallcaps}-glutamyl-meso-diaminopimelic acid that is found in PGN from most Gram-negative bacteria and certain Gram-positive bacteria. Stimulation of NOD1 or NOD2 results in the activation of the adaptor protein receptor-interacting protein 2 (RIP2; also called RICK) which promotes the activation of NF-κB and MAPKs pathway leading to transcription of numerous genes involved in inflammation and host defense. NOD1 and NOD2 are involved in the sensing of several pathogenic bacteria, including *Salmonella*, and has been reviewed in detail elsewhere (Inohara and Nunez, [@B21]; Franchi et al., [@B9]). The first attempt to characterize the role of NOD2 in *Salmonella* infection was performed in human DCs carrying a homozygous loss-of-function NOD2 L1007fs mutation and showed a decreased production of proinflammatory cytokines compared to DCs from healthy individuals (Salucci et al., [@B40]). Subsequent studies investigated the role of NOD1 and NOD2 in epithelial cells and found that the proinflammatory response induced by *Salmonella* was dependent on the SPI-1 and a set of effectors proteins (including SopE and SopE2), but was independent of Rip2 (Bruno et al., [@B5]). However, recent evidence suggests that NOD1 and NOD2 may restrict bacterial replication independent of NF-κB activation. For example, NOD1 and NOD2 can sense certain bacteria through the stimulation of the autophagic response in a Rip2- and NF-κB independent fashion (Travassos et al., [@B46]). In addition, exogenous stimulation of NOD2 via MDP further enhances both the autophagic response and *Salmonella* killing (Homer et al., [@B20]). In mice, infection with wild-type *Salmonella* failed to reveal a major role for NOD1 or NOD2 in host defense (Le Bourhis et al., [@B26]; Geddes et al., [@B13]). However, a role for NOD1 and NOD2 was revealed when mice were infected with a bacterial mutant deficient in SPI-1 or when *Salmonella* was cultured in a manner that favors the expression of SPI-2 (Le Bourhis et al., [@B26]; Geddes et al., [@B13]), suggesting that the contribution of NOD1 and NOD2 in the host defense response against *Salmonella* is dependent on the expression of *Salmonella* virulence factors.

Inflammasomes in *Salmonella* Infection
=======================================

Inflammasomes are molecular complexes that regulate the activation of the proteolytic enzyme caspase-1 (Franchi et al., [@B8]). Four different inflammasome has been functionally characterized. The NLRP1 inflammasome is activated by MDP and anthrax lethal toxin. The NLRC4 is activated by cytosolic flagellin. The NLRP3-inflammasome is activated by a variety of stimuli of microbial origins as well as particulate matter and danger signals. The AIM2 inflammasome is activated by cytosolic DNA (Franchi et al., [@B8]).

In macrophages, *Salmonella* induces the activation of caspase-1 necessary for the maturation of the proinflammatory cytokines IL-1β and IL-18. The activation of caspase-1 also induces a form of cell death called pyroptosis that has feature of both apoptosis (such as the activation of caspases) and necrosis (such as the permeabilization of the cellular membrane; Fink and Cookson, [@B6]) and that may play a role in host defense independent of cytokine production (Miao et al., [@B31]).

Initial studies aimed at identifying the inflammasome responsible for the activation of caspase-1 in macrophages infected with *Salmonella* revealed a crucial role of NLRC4 (also called IPAF; Mariathasan et al., [@B28]). Subsequently, we and others have found that NLRC4 senses cytosolic flagellin. In fact, macrophages infected with *Salmonella* mutants lacking flagellin possess an impaired ability to induce caspase-1 activation, IL-1β production, and cell death (Amer et al., [@B2]; Franchi et al., [@B7]; Miao et al., [@B29]). In addition, macrophages infected with a *Salmonella* mutant carrying a point mutation in the C-terminal region of flagellin are impaired in their ability to induce the activation of the NLRC4-inflammasome (Franchi et al., [@B7]). Furthermore, cytosolic delivery of purified flagellin, but not other microbial molecules, activates caspase-1 in an NLRC4-dependent manner (Amer et al., [@B2]; Franchi et al., [@B7]; Miao et al., [@B29]). Consistent with the role of cytosolic flagellin, TLR5-deficient macrophages show no impairment in the activation of caspase-1 induced by *Salmonella* or cytosolic flagellin (Franchi et al., [@B7]; Miao et al., [@B29]). Subsequent studies using macrophages infected with *Legionella pneumophila* (Amer et al., [@B2]; Zamboni et al., [@B51]) or *Pseudomonas aeruginosa* (Franchi et al., [@B12]; Miao et al., [@B30]) and their mutants lacking flagellin confirmed the role of NLRC4 in the activation of caspase-1 induced by cytosolic flagellin. In the case of *L. pneumophila*, but not *P. aeruginosa* or *Salmonella*, the recognition of flagellin by NLRC4 has been suggested to be mediated by the NLR family member NAIP5 (Lightfield et al., [@B27]). However NAIP5 can restrict *L. pneumophila* growth independently of caspase-1 activation suggesting that the host defense response mediated by NAIP5 proceeds independently of the NLRC4-inflammasome (Lamkanfi et al., [@B24]). NLRC4 is also important in the activation of caspase-1 induced by *Shigella*, a non-flagellated bacteria, indicating that the existence of a flagellin-independent pathway that leads to the activation of the NLRC4-inflammasome (Suzuki et al., [@B44]). There is also evidence suggesting that other proteins of the type III secretion system which share homology with flagellin can stimulate the NLRC4-inflammasome (Miao et al., [@B32]).

The activation of caspase-1 induced by *Salmonella*, *L. pneumophila*, or *P. aeruginosa* requires a functional bacterial secretion system (Franchi et al., [@B11]). The observation that during *Salmonella* infection the type III secretion system encoded by SPI-1 is required for both the translocation of flagellin into the cytosol and the activation of caspase-1 (Sun et al., [@B43]), suggests that small amounts of flagellin may inadvertently leak into the cytosol when bacterial secretion systems puncture cellular membranes.

The role of inflammasomes in *Salmonella* infection *in vivo* has been investigated in caspase-1 deficient mice. Initial work with caspase-1 deficient mice in a B10.RIII background revealed a dramatic phenotype suggesting that *Salmonella* require caspase-1 for bacterial dissemination (Monack et al., [@B34]). These results are at odds with the role of caspase-1 in other models of bacterial infection (Franchi et al., [@B11]). More recently, the role of caspase-1 in *Salmonella* infection has been reexamined in caspase-1 deficient mice in the B6 background (Lara-Tejero et al., [@B25]; Raupach et al., [@B38]). These experiments showed an increased susceptibility of caspase-1 knockout mice which was associated with increased bacterial loads in the spleen and the mesenteric lymph nodes (Lara-Tejero et al., [@B25]; Raupach et al., [@B38]). In agreement with a role for caspase-1 in the systemic phase of the infection, caspase-1 deficient mice were more susceptible than wild-type mice when challenged with *Salmonella* intraperitoneally (Raupach et al., [@B38]). Using IL-1β and IL-18 knockout mice, IL-18 was revealed as the main cytokine responsible for host defense (Raupach et al., [@B38]). While caspase-1 has a protective role against *Salmonella* infection, there is also evidence that caspase-1 has a detrimental role in septic shock. Furthermore, in a mouse model in which septic shock was induced by intraperitoneal injection of high doses of an attenuated *Salmonella* strain, caspase-1 and IL-18 deficient mice, but not IL-1β deficient mice, were protected (Raupach et al., [@B38]). Furthermore, NLRC4-deficient mice have been shown to be equally susceptible as wild-type mice (Lara-Tejero et al., [@B25]), a result that is not surprising considering that *Salmonella* is known to down regulate the expression of flagellin during the systemic phase of the infection (Alaniz et al., [@B1]). In contrast, NLRC4 plays an important role in the host defense response toward *Salmonella* mutants that express flagellin during the systemic phase of the infection (Miao et al., [@B31]).

Another inflammasome involved in both microbial and non-microbial signaling pathways is the NLRP3-inflammasome. The mechanism of activation of the NLRP3-inflammasome is complex, in that its activation requires two different signals. One signal provided by microbial ligands or endogenous cytokines is necessary to prime macrophages through the upregulation of NLRP3 and pro-IL-1β. The second signal directly triggers caspase-1 activation, and can be mediated by at least four separate pathways that include ATP-P2X7R-pannexin-1, Syk signaling, particulate matters (such as silica and urate crystals), and bacterial exotoxins (Franchi et al., [@B8], [@B10]). Although disruption of the lysosomal membrane and/or production of reactive oxygen species (ROS) and/or decrease in K+ cytosolic concentration have been implicated the activation of the NLRP3-inflammasome, the molecular mechanisms responsible for the activation of the NLRP3-inflammasome remain elusive.

A role of the NLRP3-inflammasome in the control of *Salmonella* infection was initially excluded based on the fact that NLRP3-deficient mice were as susceptible as wild-type mice to *Salmonella* infection (Lara-Tejero et al., [@B25]). More recently, Broz et al. ([@B4]) investigated whether the lack of phenotype in NLRC4- and NLRP3-deficient mice was due to redundant functions of these two inflammasomes and found that mice deficient in both NLRP3 and NLRC4 are more susceptible than wild-type mice to *Salmonella* infection similar to caspase-1 deficient mice. Using a combination of bacterial mutants and specific experimental procedures to maximize the expression of SPI-2, Broz et al. found that in macrophages infected with *Salmonella* that do not express SPI-1 the activation of caspase-1 occurs via the NLRP3-inflammasome and is dependent on SPI-2. These data suggest the existence of two different pathways (Figure [1](#F1){ref-type="fig"}), one dependent on SPI-1, NLRC4, and flagellin that triggers a robust activation of caspase-1 within minutes after infection, and a second pathway dependent on SPI-2 and NLRP3 that triggers the activation of caspase-1 with slower kinetics. The molecular mechanisms by which SPI-2 activates the NLRP3-inflammasome remain unknown. Surprisingly Apoptosis-associated Speck-like protein containing a CARD (ASC), a common adaptor protein used by both NLRC4 and NLRP3 to activate caspase-1 and to trigger the production of IL-1β, has no effect on susceptibility to *Salmonella* infection (Lara-Tejero et al., [@B25]).

![**Schematic representation of the pathways leading to caspase-1 activation in cells infected with *Salmonella***. In macrophages **(A,B)** *Salmonella* induces the activation of the NLRC4-inflammasome via flagellin and SPI-1 **(A)** and the NLRP3-inflammasome via SPI-2. **(C)** In cells of non-hematopoietic origin *Salmonella* induces the activation of the inflammasome via SopE and SPI-1. See text for more detail.](fmicb-02-00008-g001){#F1}

A third pathway (Figure [1](#F1){ref-type="fig"}) of caspase-1 activation has recently been identified. Experiments using epithelial cell lines suggest that the virulence factor SopE encoded by the SPI-1 is able to induce caspase-1 activation (Muller et al., [@B35]). Furthermore, bone-marrow chimera experiments showed that *Salmonella* mutants that selectively express the virulence factor SopE could induce the activation of caspase-1 in cells of non-hematopoietic origin (Muller et al., [@B35]). The SopE-dependent activation of caspase-1 in cells of non-hematopoietic origin was found to play a significant role in gut inflammation, but was not sufficient to restrict bacterial replication (Muller et al., [@B35]). It remains to be determined whether the SopE-dependent activation of caspase-1 is NLRC4 or NLRP3 dependent.

Concluding Remarks
==================

In this review, I have summarized recent advances in our understanding of the role of NLRs in the innate immune response to *Salmonella*. The available data suggest that the main role of inflammasomes is to restrict the replication of the bacteria during the systemic phase of the infection. In macrophages, the activation of the NLRC4-inflammasome requires SPI-1 and cytosolic flagellin. In macrophages infected with bacteria that do not express SPI-1 and flagellin a second pathway dependent on NLRP3 and the expression of SPI-2 is revealed. A third pathway that can lead to the activation of caspase-1 in non-hematopoietic cells is dependent on SPI-1 and the virulence factor SopE. *In vivo* both the NLRC4- and NLRP3-inflammasome are required for the innate immune response to *Salmonella*. It will be interesting in future studies to explore the role of inflammasomes in the activation of adaptive immune responses elicited by *Salmonella*.
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